Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Cash Flow Reinvestment Rate
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. cash flow reinvestment rate. Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) has a Cash Flow Reinvestment Rate of 0.18x as of September 2024, reinvesting TL5.93 Million (capex TL2.91 Million plus investments TL-3.03 Million) from operating cash flow of TL33.37 Million. Explore Oncosem Onkolojik Sistemler Sanayi ve Ti (ONCSM) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (2020–2022)
Cash flow reinvestment rate of Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. from 2020 to 2022. Historical reinvestment intensity for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. across 3 annual periods. Explore reinvestment intensity of Oncosem Onkolojik Sistemler Sanayi ve Ti to see what proportion of operating cash flow is directed to capital expenditures.
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Cash Flow Reinvestment Rate by Year (2020–2022)
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. cash flow reinvestment rate by year from 2020 to 2022. Year-by-year capital reinvestment analysis for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.. For the full cash flow conversion analysis, see cash efficiency ratio of Oncosem Onkolojik Sistemler Sanayi ve Ti.
| Year | Reinvestment Rate | Total Reinvested (TRY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 1.01x | TL53.09 Million | TL52.69 Million | TL26.02 Million | ▲ +38.0% |
| 2021 | 0.73x | TL37.73 Million | TL51.68 Million | TL0.00 | ▼ -12.7% |
| 2020 | 0.84x | TL16.23 Million | TL19.41 Million | TL0.00 | — |